Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Supplementary Figure S6 from A Model of Intratumor and Interpatient Heterogeneity Explains Clinical Trials of Curative Combination Therapy for Lymphoma
Home
Publications
Supplementary Figure S6 from A Model of Intratumor and Interpatient Heterogeneity Explains Clinical Trials of Curative Combination Therapy for Lymphoma
Supplementary Figure S6 from A Model of Intratumor and Interpatient Heterogeneity Explains Clinical Trials of Curative Combination Therapy for Lymphoma
Authors:
AP
Amy E. Pomeroy
Amy E. Pomeroy
AP
Adam C. Palmer
Adam C. Palmer
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Open Access
Publisher website
Google Scholar
17 June 2026
other
Published by
American Association for Cancer Research (AACR)
DOI:
10.1158/2643-3230.32696820
Abstract
Treatment with RCHOP decreases patients’ sensitivities to RCHOP and novel agents
Keywords
SUPPLEMENTARY FIGURE
INTERPATIENT HETEROGENEITY
HETEROGENEITY EXPLAINS
EXPLAINS CLINICAL
CLINICAL TRIALS
CURATIVE COMBINATION
COMBINATION THERAPY
LYMPHOMA TREATMENT
RCHOP DECREASES
DECREASES PATIENTS’
Related articles
Scroll to top